[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Food and Drug Administration (FDA)
Frequently Asked Questions How common are heart palpitations with tirzepatide? Heart palpitations occur in approximately 25% of patients taking tirzepatide, based on data from the SURMOUNT clinical trial program
The GMC reviewed this and concluded that the case required no further action. UKA, meanwhile, said: A small number of British athletes have used L-carnitine and, to our knowledge, all doses and methods of administration have been fully in accordance with Wada protocol
Yu G, Wang LG, Han Y, et al
Interestingly, we found no significant difference among studied administrated routes in all other CBC parameters such as Hb, MCV, platelets count, WBC count, and homocysteine level
doi: 10.3389/fphar.2021.653887